These and other data suggest many patients needing adjuvant chemotherapy may safely avoid anthracyclines to reduce ... tailored treatment paradigms based on the extent of response to neoadjuvant ...
Chapter 2 of Appraisal and funding of cancer drugs from July 2016 (including the new Cancer Drugs Fund) – A new deal for patients, taxpayers and industry states that for those drugs with a draft ...
Systemic adjuvant treatment includes chemotherapy and radiotherapy. But the optimal scheduling is not known. Recently proposed sequential chemo-radiotherapy as sandwich therapy for high risk ...
The FDA has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant ... after chemo. Results of the PROpel trial were reported last September, and made Lynparza the first PARP drug to show ...